In this episode of our WTR Small Cap Spotlight, we sat down with LifeVantage (NASDAQ: LFVN ) CEO Steve Fife and CMO Julie Boyster to drill down on the science of nutrigenomics, which is the study of how nutrients impact our genes, and how LifeVantage’s proprietary formulations of naturally found ingredients work together to activate genes and help improve overall health and wellbeing. Recent clinical studies further demonstrate the efficacy of the company’s new patent-pending MindBody GLP-1 System, and the company discusses additional synergistic benefits from combining MindBody with the company’s flagship Nrf2 Synergizer.